Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Di Maio

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Minerva Cardiology and Angiology|September 15, 2023
Retraction of: "Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fraction"Renato DE Vecchis, Andrea Paccone, Marco DI Maio
Minerva Cardioangiologica|February 22, 2020
Withdrawn: Effects of a restricted water intake on various clinical and laboratory outcomes in patients with heart failure: a meta-analysis of randomized controlled trialsRenato De Vecchis, Andrea Paccone, Marco Di Maio
Minerva Cardioangiologica|February 22, 2020
Withdrawn: Health-related quality of life and unscheduled re-hospitalizations after coronary revascularization: significant predictive role of the MacNew questionnaireRenato De Vecchis, Andrea Paccone, Marco Di Maio
Minerva Cardioangiologica|October 19, 2019
Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fractionRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|June 30, 2020
Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/ValsartanRenato De Vecchis, Andrea Paccone, Marco Di Maio
Journal of Clinical Medicine Research|February 26, 2020
Favorable Effects of Sacubitril/Valsartan on the Peak Atrial Longitudinal Strain in Patients With Chronic Heart Failure and a History of One or More Episodes of Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 19, 2019
Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort studyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|August 16, 2019
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|October 23, 2019
Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|April 26, 2019
Rate Control Yields Better Clinical Outcomes Over a Median Follow-Up of 20 Months Compared to Rhythm Control Strategy in Patients With a History of Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Marco Di Maio, Silvia Soreca, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Minerva Cardiology and Angiology|September 15, 2023
Retraction of: "Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fraction"Renato DE Vecchis, Andrea Paccone, Marco DI Maio
Minerva Cardioangiologica|February 22, 2020
Withdrawn: Effects of a restricted water intake on various clinical and laboratory outcomes in patients with heart failure: a meta-analysis of randomized controlled trialsRenato De Vecchis, Andrea Paccone, Marco Di Maio
Minerva Cardioangiologica|February 22, 2020
Withdrawn: Health-related quality of life and unscheduled re-hospitalizations after coronary revascularization: significant predictive role of the MacNew questionnaireRenato De Vecchis, Andrea Paccone, Marco Di Maio
Minerva Cardioangiologica|October 19, 2019
Sacubitril/valsartan improves left ventricular longitudinal deformation in heart failure patients with reduced ejection fractionRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|June 30, 2020
Upstream Therapy for Atrial Fibrillation Prevention: The Role of Sacubitril/ValsartanRenato De Vecchis, Andrea Paccone, Marco Di Maio
Journal of Clinical Medicine Research|February 26, 2020
Favorable Effects of Sacubitril/Valsartan on the Peak Atrial Longitudinal Strain in Patients With Chronic Heart Failure and a History of One or More Episodes of Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|December 19, 2019
Atrial mechanical hypofunction after electrical cardioversion of persistent or long-lasting persistent atrial fibrillation: a retrospective cohort studyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|August 16, 2019
Secondary Prevention of Nonvalvular Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|October 23, 2019
Sacubitril/Valsartan Therapy for 14 Months Induces a Marked Improvement of Global Longitudinal Strain in Patients With Chronic Heart Failure: A Retrospective Cohort StudyRenato De Vecchis, Andrea Paccone, Marco Di Maio
Cardiology Research|April 26, 2019
Rate Control Yields Better Clinical Outcomes Over a Median Follow-Up of 20 Months Compared to Rhythm Control Strategy in Patients With a History of Atrial Fibrillation: A Retrospective Cohort StudyRenato De Vecchis, Marco Di Maio, Silvia Soreca, et al.
Pageof 9